Lódi Mária
DE >
ÁOKPh.D hallgató 2016-
Publication list
2022
Hassoun, R.,
Budde, H.,
Zhazykbayeva, S.,
Herwig, M.,
Sieme, M.,
Delalat, S.,
Mostafi, N.,
Gömöri, K.,
Tangos, M.,
Jarkas, M.,
Pabel, S.,
Bruckmüller, S.,
Skrygan, M.,
Lódi, M.,
Jaquet, K.,
Sequeira, V.,
Gambichler, T.,
Remedios, C.,
Kovács, Á.,
Mannherz, H.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
Int. J. Cardiol. 347 44-45, 2022.
Tangos, M.,
Budde, H.,
Kolijn, D.,
Sieme, M.,
Zhazykbayeva, S.,
Lódi, M.,
Herwig, M.,
Gömöri, K.,
Hassoun, R.,
Robinson, E.,
Meister, T.,
Jaquet, K.,
Kovács, Á.,
Mustroph, J.,
Evert, K.,
Babel, N.,
Fagyas, M.,
Lindner, D.,
Püschel, K.,
Westermann, D.,
Mannherz, H.,
Paneni, F.,
Pfaender, S.,
Tóth, A.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
SARS-CoV-2 infects human cardiac myocytes promoted by inflammation and oxidative stress.
Int. J. Cardiol. 362 196-205, 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
2021
Kolijn, D.,
Pabel, S.,
Tian, Y.,
Lódi, M.,
Herwig, M.,
Carrizzo, A.,
Zhazykbayeva, S.,
Kovács, Á.,
Fülöp, G.,
Falcao-Pires, I.,
Reusch, P.,
Linthout, S.,
Papp, Z.,
Heerebeek, L.,
Vecchione, C.,
Maier, L.,
Ciccarelli, M.,
Tschöpe, C.,
Mügge, A.,
Bagi, Z.,
Sossalla, S.,
Hamdani, N.:
Empagliflozin Improves Endothelial and Cardiomyocyte Function in Human Heart Failure With Preserved Ejection Fraction via Reduced Pro-Inflammatory-Oxidative Pathways and Protein Kinase Gα Oxidation.
Cardiovasc. Res. 117 (2), 495-507, 2021.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
D1 Physiology
D1 Physiology (medical)
Bánhegyi, V.,
Enyedi, A.,
Fülöp, G.,
Oláh, A.,
Mányiné Siket, I.,
Váradi, C.,
Bottyán, K.,
Lódi, M.,
Csongrádi, A.,
Umar, M.,
Fagyas, M.,
Czuriga, D.,
Édes, I.,
Pólos, M.,
Merkely, B.,
Csanádi, Z.,
Papp, Z.,
Szabó, G.,
Radovits, T.,
Takács, I.,
Tóth, A.:
Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart.
Cells. 10 (7), 1-13, 2021.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Hassoun, R.,
Budde, H.,
Zhazykbayeva, S.,
Herwig, M.,
Sieme, M.,
Delalat, S.,
Mostafi, N.,
Gömöri, K.,
Tangos, M.,
Jarkas, M.,
Pabel, S.,
Bruckmüller, S.,
Skrygan, M.,
Lódi, M.,
Jaquet, K.,
Sequeira, V.,
Gambichler, T.,
Remedios, C.,
Kovács, Á.,
Mannherz, H.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
Int. J. Cardiol. 344 160-169, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Budde, H.,
Hassoun, R.,
Tangos, M.,
Zhazykbayeva, S.,
Herwig, M.,
Varatnitskaya, M.,
Sieme, M.,
Delalat, S.,
Sultana, I.,
Kolijn, D.,
Gömöri, K.,
Jarkas, M.,
Lódi, M.,
Jaquet, K.,
Kovács, Á.,
Mannherz, H.,
Sequeira, V.,
Mügge, A.,
Leichert, L.,
Sossalla, S.,
Hamdani, N.:
The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts.
Antioxidants. 10 (7), 1-26, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
2020
Reil, J.,
Reil, G.,
Kovács, Á.,
Sequeira, V.,
Waddingham, M.,
Lódi, M.,
Herwig, M.,
Ghaderi, S.,
Kreusser, M.,
Papp, Z.,
Voigt, N.,
Dobrev, D.,
Meyhöfer, S.,
Langer, H.,
Maier, L.,
Linz, D.,
Mügge, A.,
Hohl, M.,
Steendijk, P.,
Hamdani, N.:
CaMKII Activity Contributes to Homeometric Autoregulation of the Heart: a Novel Mechanism for the Anrep Effect.
J. Physiol.-London. 598 (15), 3129-3153, 2020.
Journal metrics:
Q1 Physiology
D1 Sports Science
Kolijn, D.,
Kovács, Á.,
Herwig, M.,
Lódi, M.,
Sieme, M.,
Alhaj, A.,
Sandner, P.,
Papp, Z.,
Reusch, P.,
Haldenwang, P.,
Falcao-Pires, I.,
Linke, W.,
Jaquet, K.,
Linthout, S.,
Mügge, A.,
Tschöpe, C.,
Hamdani, N.:
Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator.
Front. Physiol. 11 1-21, 2020.
Journal metrics:
Q2 Physiology
Q2 Physiology (medical)
Herwig, M.,
Kolijn, D.,
Lódi, M.,
Hölper, S.,
Kovács, Á.,
Papp, Z.,
Jaquet, K.,
Haldenwang, P.,
Dos Remedios, C.,
Reusch, P.,
Mügge, A.,
Krüger, M.,
Fielitz, J.,
Linke, W.,
Hamdani, N.:
Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D.
Front. Physiol. 11 240, 2020.
Journal metrics:
Q2 Physiology
Q2 Physiology (medical)
Lódi, M.,
Bánhegyi, V.,
Bódi, B.,
Gyöngyösi, A.,
Kovács, Á.,
Árokszállási, A.,
Hamdani, N.,
Fagyas, M.,
Édes, I.,
Csanádi, Z.,
Czuriga, I.,
Kisvárday, Z.,
Lekli, I.,
Bai, P.,
Tóth, A.,
Papp, Z.,
Czuriga, D.:
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 18 (1), 470, 2020.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2019
Lódi, M.,
Priksz, D.,
Fülöp, G.,
Bódi, B.,
Gyöngyösi, A.,
Nagy, L.,
Kovács, Á.,
Kertész, A.,
Kocsis, J.,
Édes, I.,
Csanádi, Z.,
Czuriga, I.,
Kisvárday, Z.,
Juhász, B.,
Lekli, I.,
Bai, P.,
Tóth, A.,
Papp, Z.,
Czuriga, D.:
Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 17 229, 2019.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2017
Nagy, L.,
Gődény, I.,
Nánási, P.,
Leskó, Á.,
Balogh, L.,
Bánhegyi, V.,
Bódi, B.,
Csípő, T.,
Csongrádi, A.,
Fülöp, G.,
Kovács, Á.,
Lódi, M.,
Papp, Z.:
A szív pozitív inotróp támogatása a miozin-aktivátor hatású omecamtiv-mecarbil segítségével.
Cardiol. Hung. 47 (1), 69-76, 2017.
Nagy, A.,
Lódi, M.,
Balogh, I.,
Czuriga, D.,
Kocsis, J.:
Az onkokardiológiai ellátás új irányelvei.
Magyar Onkol. 61 (3), 219-227, 2017.
Journal metrics:
Q4 Medicine (miscellaneous)
Q4 Oncology
Gulácsi-Bárdos, P.,
Szokol, M.,
Lódi, M.,
Czuriga, D.,
Czuriga, I.,
Édes, I.,
Nagy, A.,
Sármán, B.:
Ischaemiás szívbetegség és tumoros betegségek együttes előfordulása: kérdések és problémák.
Orvosi Hetilap. 158 (43), 1691-1697, 2017.
Journal metrics:
Q4 Medicine (miscellaneous)
updated: 2024-11-10, 01:24
